CoChat

Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes

Open access
Feliciano, Pamela, Zhou, Xueya, Astrovskaya, Irina, Turner, Tychele N., Wang, Tianyun, Brueggeman, Leo, Barnard, Rebecca, Hsieh, Alexander, Snyder, LeeAnne Green, Muzny, Donna M., Sabo, Aniko, The SPARK Consortium, Abbeduto, Leonard, Acampado, John, Ace, Andrea J., Albright, Charles, Alessandri, Michael, Amaral, David G., Amatya, Alpha, Annett, Robert D., Arriaga, Ivette, Bahl, Ethan, Balasubramanian, Adithya, Bardett, Nicole, Bashar, Asif, Beaudet, Arthur, Beeson, Landon, Bernier, Raphael A., Berry-Kravis, Elizabeth, Booker, Stephanie, Brewster, Stephanie J., Brooks, Elizabeth, Butler, Martin E., Butter, Eric M., Callahan, Kristen, Camba, Alexies, Carpenter, Sarah, Carriero, Nicholas, Cartner, Lindsey A., Chatha, Ahmad S., Chin, Wubin, Clark, Renee D., Cohen, Cheryl, Courchesne, Eric, Cubells, Joseph F., Currin, Mary Hannah, Daniels, Amy M., DeMarco, Lindsey, Dennis, Megan Y., Dichter, Gabriel S., Ding, Yan, Dinh, Huyen, Doan, Ryan, Doddapaneni, HarshaVardhan, Eldred, Sara, Eng, Christine, Erickson, Craig A., Esler, Amy, Fatemi, Ali, J. Fischer, Gregory, Fisk, Ian, Fombonne, Eric J., Fox, Emily A., Francis, Sunday, Friedman, Sandra L., Ganesan, Swami, Garrett, Michael, Gazestani, Vahid, Geisheker, Madeleine R., Gerdts, Jennifer A., Geschwind, Daniel H., Goin-Kochel, Robin P., Griswold, Anthony J., Grosvenor, Luke P., Gruber, Angela J., Gulsrud, Amanda C., Gunderson, Jaclyn, Gutierrez, Anibal, Hale, Melissa N., Haley, Monica, Hall, Jacob B., Hamer, Kira E., Han, Bing, Hanna, Nathan, Harkins, Christina, Harris, Nina, Hauf, Brenda, Hayes, Caitlin, Hepburn, Susan L., Herbert, Lynette M., Heyman, Michelle, Phillips, Brittani A., Horner, Susannah, Hu, Jianhong, Huang-Storms, Lark Y., Hutter, Hanna, Istephanous, Dalia, Jacob, Suma, Jensen, William, Jones, Mark, Jordy, Michelle, Juarez, A. Pablo, Kanne, Stephen, Kaplan, Hannah E., Kent, Matt, Kitaygorodsky, Alex, Koomar, Tanner, Korchina, Viktoriya, Krentz, Anthony D., Schneider, Hoa Lam, Lamarche, Elena, Landa, Rebecca J., Lash, Alex E., Law, J. Kiely, Lawson, Noah, Layman, Kevin, Lechniak, Holly, Lee, Sandra, Lee, Soo J., Coury, Daniel Lee, Martin, Christa Lese, Li, Deana, Li, Hai, Lillie, Natasha, Liu, Xiuping, Lord, Catherine, Mallardi, Malcolm D., Manning, Patricia, Manoharan, Julie, Marini, Richard, Marzano, Gabriela, Mason, Andrew, Matthews, Emily T., McCracken, James T., McKenzie, Alexander P., Momin, Zeineen, Morrier, Michael J., Murali, Shwetha, Myers, Vincent J., Neely, Jason, Nessner, Caitlin, Nicholson, Amy, O’Brien, Kaela, O’Connor, Eirene, Ochoa-Lubinoff, Cesar, Orobio, Jessica, Ousley, Opal Y., Pacheco, Lillian D., Pandey, Juhi, Paolicelli, Anna Marie, Pawlowski, Katherine G., Pierce, Karen L., Piven, Joseph, Plate, Samantha, Popp, Marc, Pramparo, Tiziano, Prock, Lisa M., Qi, Hongjian, Qiu, Shanping, Rachubinski, Angela L., Rajbhandari, Kshitij, Rana, Rishiraj, Remington, Rick, Rice, Catherine E., Rigby, Chris, Robertson, Beverly E., Roeder, Katherine, Rosenberg, Cordelia R., Russo-Ponsaran, Nicole, Ruzzo, Elizabeth, Sahin, Mustafa, Salomatov, Andrei, Sandhu, Sophia, Santangelo, Susan, Sarver, Dustin E., Scherr, Jessica, Schultz, Robert T., Schweers, Kathryn A., Shah, Swapnil, Shaikh, Tamim, Shocklee, Amanda D., Simon, Laura, Simon, Andrea R., Singh, Vini, Skinner, Steve, Smith, Kaitlin, Smith, Christopher J., Soorya, Latha V., Soucy, Aubrie, Stephens, Alexandra N., Stock, Colleen M., Sutcliffe, James S., Swanson, Amy, Tafolla, Maira, Takahashi, Nicole, Thomas, Taylor, Thomas, Carrie, Thompson, Samantha, Tjernagel, Jennifer, Van Metre, Bonnie, Veenstra-Vanderweele, Jeremy, Vernoia, Brianna M., Wallace, Jermel, Walston, Corrie H., Wang, Jiayao, Warren, Zachary, Wasserburg, Lucy, White, Loran Casey, White, Sabrina, Wodka, Ericka L., Xu, Simon, Yang, Wha S., Yinger, Meredith, Yu, Timothy, Zang, Lan, Zaydens, Hana, Zhang, Haicang, Zhao, Haoquan, Gibbs, Richard A., Eichler, Evan E., O’Roak, Brian J., Michaelson, Jacob J., Volfovsky, Natalia, Shen, Yufeng, Chung, Wendy K. · 2019 · npj Genomic Medicine

Published version of a preprint

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index; 12 of the 37 sources its claims cite were checked for support.

Abstract

Autism spectrum disorder (ASD) is a genetically heterogeneous condition, caused by a combination of rare de novo and inherited variants as well as common variants in at least several hundred genes. However, significantly larger sample sizes are needed to identify the complete set of genetic risk factors. We conducted a pilot study for SPARK (SPARKForAutism.org) of 457 families with ASD, all consented online. Whole exome sequencing (WES) and genotyping data were generated for each family using DNA from saliva. We identified variants in genes and loci that are clinically recognized causes or significant contributors to ASD in 10.4% of families without previous genetic findings. In addition, we identified variants that are possibly associated with ASD in an additional 3.4% of families. A meta-analysis using the TADA framework at a false discovery rate (FDR) of 0.1 provides statistical support for 26 ASD risk genes. While most of these genes are already known ASD risk genes, BRSK2 has the strongest statistical support and reaches genome-wide significance as a risk gene for ASD ( p -value = 2.3e−06). Future studies leveraging the thousands of individuals with ASD who have enrolled in SPARK are likely to further clarify the genetic risk factors associated with ASD as well as allow accelerate ASD research that incorporates genetic etiology.

Overview

CoChat Summary

TL;DR

This SPARK pilot exome-sequencing study of 457 online-recruited autism families found returnable ASD-related genetic findings in 10.4% of families without prior genetic findings and possible ASD-associated variants in an additional 3.4%. A TADA meta-analysis with published trios supported 26 ASD risk genes at FDR ≤ 0.1, with BRSK2 reaching genome-wide significance.

Key findings

  • In 444 families without prior genetic findings, deleterious variants in known ASD risk genes/loci were identified in 50 families (10.4%); possible ASD-associated variants were found in an additional 14 individuals (3.4%). Thirteen self-reported genetic diagnoses were confirmed and served as positive controls.
  • De novo analysis identified 647 rare coding/splice SNVs and indels (1.4/offspring), including 85 LGD and 390 missense variants. The dnLGD frequency was 0.18/offspring, 1.76-fold above baseline expectation (p = 1.2 × 10−6); de novo D-mis variants with CADD ≥25 were enriched 1.28-fold (p = 6.6 × 10−4), and those with MPC ≥2 were enriched 1.88-fold (p = 9.9 × 10−4).
  • TADA meta-analysis of 4773 published ASD trios plus 465 SPARK trios identified 67 genes at FDR ≤ 0.1; 26 also had a damaging variant in SPARK. Six genes reached FDR ≤ 0.1 only after SPARK inclusion: BRSK2, ITSN1, PAX5, FEZF2, DMWD, and CPZ. BRSK2 had the strongest support and reached genome-wide significance (p = 2.3 × 10−6; FDR q = 0.0015).
  • CNV analysis found 273 rare CNVs in 206 affected offspring, including 253 inherited CNVs (0.544/affected offspring; average 194 kb) and 20 de novo CNVs (0.043/affected offspring; average 1.6 Mb). Six CNVs mapped to 16p11.2, and four occurred at BP4-BP5 in 0.9% of affected offspring. Mosaic analysis identified 65 likely mosaic mutations (0.142/offspring), about 10% (65/652) of total de novo SNVs.

Methods

  • SPARK pilot recruited 457 families with ASD online under a centralized IRB; 1379 individuals were characterized, including 418 simplex and 39 multiplex families. DNA came from saliva; exome capture used VCRome plus PKv2 and sequencing used Illumina HiSeq 100 bp paired-end reads, with Illumina HumanCoreExome 550K SNP genotyping.
  • De novo SNV/indel calls were generated independently by UW, SF, and CUMC and combined by consensus; inherited singleton LGD variants, mosaic SNVs, CNVs, and aneuploidies were called with separate pipelines. CNVs were integrated from exome read-depth and SNP microarray data.
  • Main analyses included burden testing against a published mutation-rate model using Poisson tests, TADA meta-analysis with published ASD trios, and functional/network analyses using forecASD, STRING, Gene Ontology, BrainSpan laminar expression, and single-cell expression data.

Limitations

  • Stated in the paper: the pilot sample size was limited; the study was underpowered to detect statistically significant sex differences in burden; mosaic calls were too few to evaluate mosaic mutation burden; DMWD may be a false positive because it is not constrained (pLI = 0); larger samples are needed to identify lower-penetrance inherited risk genes.
  • Stated in the paper: diagnostic yield may increase as more SPARK individuals are studied and additional risk factors are identified; some variants were interpreted as possible contributors and would be returned only if genes become established.
  • Evident from the text: phenotypes were largely parent-reported online rather than clinically confirmed for all participants; over 80% of participants were predicted to have European ancestry, limiting generalizability; no incidental findings unrelated to ASD were searched for; platform differences may cause some CNVs to be missed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41525-019-0093-8

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Meta-analysis using the TADA framework identifies 34 genes with a false discovery rate (FDR) of ≤0.2. Known ASD genes are defined as those with SFARI Gene105 score ≤2 or implicated in a previous TADA meta-analysis (FDR ≤ 0.1)8 and known NDD genes are those listed in the DDG2P database16 and are colored orange. Deleterious missense (D-mis) variants are defined by CADD score ≥25. A total of 34 genes with at least one de novo damaging variant observed in SPARK pilot trios achieve an FDR ≤ 0.2 after meta-analysis with published trios (total n = 5238). Fourteen genes are not classified as known ASD or NDD genes. Six genes (BRSK2, ITSN1, FEZF2, PAX5, DMWD, and CPZ) that have an FDR ≤ 0.1 only after inclusion of SPARK de novo variants are highlighted. The asterisk symbol indicates genes that are not constrained (pLI < 0.5)
Fig. 1 Meta-analysis using the TADA framework identifies 34 genes with a false discovery rate (FDR) of ≤0.2. Known ASD genes are defined as those with SFARI Gene105 score ≤2 or implicated in a previous TADA meta-analysis (FDR ≤ 0.1)8 and known NDD genes are those listed in the DDG2P database16 and are colored orange. Deleterious missense (D-mis) variants are defined by CADD score ≥25. A total of 34 genes with at least one de novo damaging variant observed in SPARK pilot trios achieve an FDR ≤ 0.2 after meta-analysis with published trios (total n = 5238). Fourteen genes are not classified as known ASD or NDD genes. Six genes (BRSK2, ITSN1, FEZF2, PAX5, DMWD, and CPZ) that have an FDR ≤ 0.1 only after inclusion of SPARK de novo variants are highlighted. The asterisk symbol indicates genes that are not constrained (pLI < 0.5)CC BY · PubMed Central
Fig. 2 Network analysis and gene expression of candidate ASD risk genes. a STRING networks of forecASD genes, b STRING networks of known ASD genes, and c gene expression of human fetal cortex at postconceptual weeks (PCW) 15–16. Known ASD genes are defined as those with a SFARI Gene scores104 ≤2 (84 genes, indicated as SFARI) or implicated in a previous TADA meta-analysis8 at an FDR ≤ 0.1 (65 genes, indicated as TADA). The enrichment for each gene was measured by the t-statistics comparing the expression level in each layer against all other layers. The enrichment of a gene set is the mean of t-statistics of its genes. Two candidate ASD risk genes (PAX5 and KDM1B) are not shown due to the low expression levels in human developing cortex (RPKM <1 for at least 20% available neocortical samples in BrainSpan48). Data were extracted from Supplementary Tables of Parikshak et al.45 Laminae abbreviations: marginal zone (MZ), outer/inner cortical plate (CPo/CPi), subplate (SP), intermediate zone (IZ), outer/inner subventricular zone (SZo/SZi), ventricular zone (VZ)
Fig. 2 Network analysis and gene expression of candidate ASD risk genes. a STRING networks of forecASD genes, b STRING networks of known ASD genes, and c gene expression of human fetal cortex at postconceptual weeks (PCW) 15–16. Known ASD genes are defined as those with a SFARI Gene scores104 ≤2 (84 genes, indicated as SFARI) or implicated in a previous TADA meta-analysis8 at an FDR ≤ 0.1 (65 genes, indicated as TADA). The enrichment for each gene was measured by the t-statistics comparing the expression level in each layer against all other layers. The enrichment of a gene set is the mean of t-statistics of its genes. Two candidate ASD risk genes (PAX5 and KDM1B) are not shown due to the low expression levels in human developing cortex (RPKM <1 for at least 20% available neocortical samples in BrainSpan48). Data were extracted from Supplementary Tables of Parikshak et al.45 Laminae abbreviations: marginal zone (MZ), outer/inner cortical plate (CPo/CPi), subplate (SP), intermediate zone (IZ), outer/inner subventricular zone (SZo/SZi), ventricular zone (VZ)CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 18 Not checked · 107 Own results and interpretations

58 more claims · 1 with their cited sources checked

Create a free account to see all 133 claims and to verify the 25 references still open.

See all claims — free account
  • Probably not a substantial claim. 38
  • It may state two separate claims as one. 45

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 120 references

Cited by

See all 272

Metadata

Authors
Feliciano, P., Zhou, X., Astrovskaya, I., Turner, T. N., Wang, T., Brueggeman, L., Barnard, R., Hsieh, A., Snyder, L. G., Muzny, D. M., Sabo, A., The SPARK Consortium, Abbeduto, L., Acampado, J., Ace, A. J., Albright, C., Alessandri, M., Amaral, D. G., Amatya, A., Annett, R. D., Arriaga, I., Bahl, E., Balasubramanian, A., Bardett, N., Bashar, A., Beaudet, A., Beeson, L., Bernier, R. A., Berry-Kravis, E., Booker, S., Brewster, S. J., Brooks, E., Butler, M. E., Butter, E. M., Callahan, K., Camba, A., Carpenter, S., Carriero, N., Cartner, L. A., Chatha, A. S., Chin, W., Clark, R. D., Cohen, C., Courchesne, E., Cubells, J. F., Currin, M. H., Daniels, A. M., DeMarco, L., Dennis, M. Y., Dichter, G. S., Ding, Y., Dinh, H., Doan, R., Doddapaneni, H., Eldred, S., Eng, C., Erickson, C. A., Esler, A., Fatemi, A., J. Fischer, G., Fisk, I., Fombonne, E. J., Fox, E. A., Francis, S., Friedman, S. L., Ganesan, S., Garrett, M., Gazestani, V., Geisheker, M. R., Gerdts, J. A., Geschwind, D. H., Goin-Kochel, R. P., Griswold, A. J., Grosvenor, L. P., Gruber, A. J., Gulsrud, A. C., Gunderson, J., Gutierrez, A., Hale, M. N., Haley, M., Hall, J. B., Hamer, K. E., Han, B., Hanna, N., Harkins, C., Harris, N., Hauf, B., Hayes, C., Hepburn, S. L., Herbert, L. M., Heyman, M., Phillips, B. A., Horner, S., Hu, J., Huang-Storms, L. Y., Hutter, H., Istephanous, D., Jacob, S., Jensen, W., Jones, M., Jordy, M., Juarez, A. P., Kanne, S., Kaplan, H. E., Kent, M., Kitaygorodsky, A., Koomar, T., Korchina, V., Krentz, A. D., Schneider, H. L., Lamarche, E., Landa, R. J., Lash, A. E., Law, J. K., Lawson, N., Layman, K., Lechniak, H., Lee, S., Lee, S. J., Coury, D. L., Martin, C. L., Li, D., Li, H., Lillie, N., Liu, X., Lord, C., Mallardi, M. D., Manning, P., Manoharan, J., Marini, R., Marzano, G., Mason, A., Matthews, E. T., McCracken, J. T., McKenzie, A. P., Momin, Z., Morrier, M. J., Murali, S., Myers, V. J., Neely, J., Nessner, C., Nicholson, A., O’Brien, K., O’Connor, E., Ochoa-Lubinoff, C., Orobio, J., Ousley, O. Y., Pacheco, L. D., Pandey, J., Paolicelli, A. M., Pawlowski, K. G., Pierce, K. L., Piven, J., Plate, S., Popp, M., Pramparo, T., Prock, L. M., Qi, H., Qiu, S., Rachubinski, A. L., Rajbhandari, K., Rana, R., Remington, R., Rice, C. E., Rigby, C., Robertson, B. E., Roeder, K., Rosenberg, C. R., Russo-Ponsaran, N., Ruzzo, E., Sahin, M., Salomatov, A., Sandhu, S., Santangelo, S., Sarver, D. E., Scherr, J., Schultz, R. T., Schweers, K. A., Shah, S., Shaikh, T., Shocklee, A. D., Simon, L., Simon, A. R., Singh, V., Skinner, S., Smith, K., Smith, C. J., Soorya, L. V., Soucy, A., Stephens, A. N., Stock, C. M., Sutcliffe, J. S., Swanson, A., Tafolla, M., Takahashi, N., Thomas, T., Thomas, C., Thompson, S., Tjernagel, J., Van Metre, B., Veenstra-Vanderweele, J., Vernoia, B. M., Wallace, J., Walston, C. H., Wang, J., Warren, Z., Wasserburg, L., White, L. C., White, S., Wodka, E. L., Xu, S., Yang, W. S., Yinger, M., Yu, T., Zang, L., Zaydens, H., Zhang, H., Zhao, H., Gibbs, R. A., Eichler, E. E., O’Roak, B. J., Michaelson, J. J., Volfovsky, N., Shen, Y., & Chung, W. K.
Affiliations
  • Simons Foundation (US)
  • University of Mississippi Medical Center (US)
  • University of California, Los Angeles (US)
  • University of Iowa (US)
  • Nationwide Children's Hospital (US)
  • University of Miami (US)
  • Baylor College of Medicine (US)
  • Rush University Medical Center (US)
  • University of Washington (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • Boston Children's Hospital (US)
  • Kennedy Krieger Institute (US)
  • Emory University (US)
  • University of North Carolina at Chapel Hill (US)
  • Children's Hospital of Philadelphia (US)
  • University of Minnesota (US)
  • Manitoba Harm Reduction Network (CA)
  • Oregon Health & Science University (US)
  • University of California San Diego (US)
  • Colorado State University (US)
  • University of Missouri (US)
  • Autism & Developmental Medicine Institute (US)
  • Weill Cornell Medicine (US)
  • University of Colorado Anschutz (US)
  • Maine Medical Center Research Institute (US)
  • Columbia University Irving Medical Center (US)
  • Greenwood Genetic Center (US)
  • Southwest Autism Research & Resource Center (US)
  • Howard Hughes Medical Institute (US)
  • Columbia University (US)
  • Vanderbilt University Medical Center (US)
Venue
npj Genomic Medicine
Published
2019-08-23
Volume
4
Issue
1
Pages
19-19
ISSN
2056-7944 (ISSN-L)
OpenAlex
W2969366465
Cited by
247
References
118
Citations by year
2026: 25 · 2025: 25 · 2024: 36 · 2023: 25 · 2022: 43 · 2021: 60 · 2020: 31 · 2019: 2
FWCI
19.90
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Genomic Medicine (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • Simons Foundation (SFARI #608045)
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH101221, 1K99MH117165)
  • U.S. Department of Health & Human Services | NIH | Center for Scientific Review (MH105527, DC014489)
  • Howard Hughes Medical Institute
  • U.S. Department of Health & Human Services | National Institutes of Health (1K99MH117165, MH105527, DC014489)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
autism spectrum disorder, risk genes, exome sequencing, de novo mutations, inherited mutations, BRSK2, genetic heterogeneity, saliva genotyping

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. https://app.cochat.ai/papers/10.1038/s41525-019-0093-8
The paper
Feliciano, P., Zhou, X., Astrovskaya, I., Turner, T. N., Wang, T., Brueggeman, L., Barnard, R., Hsieh, A., Snyder, L. G., Muzny, D. M., Sabo, A., The SPARK Consortium, Abbeduto, L., Acampado, J., Ace, A. J., Albright, C., Alessandri, M., Amaral, D. G., Amatya, A., . . . Chung, W. K. (2019). Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. npj Genomic Medicine. https://doi.org/10.1038/s41525-019-0093-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.